DLTH vs VRTX · rev $626.6M vs P/E 30, rev $12.00B
Duluth Holdings Inc (DLTH) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Duluth Holdings Inc (DLTH) is a apparel retail company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported DLTH revenue for 2025-02-02 was $626.6M. Net income was -$43.6M. Revenue was down 3.1% from 2024-01-28 to 2025-02-02. DLTH currently screens at market cap $74.0M.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
DLTH currently screens at market cap $74.0M. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the DLTH and VRTX stock pages for the full models.
Not investment advice.